GOOD NEWS FOR PATIENTS WITH ARTHRITIC ANKLESPosted by Ed Davis, DPM on 5/09/05 at 22:24 (174623)
good news for patients with arthritic ankles
Good news for patients with arthritic ankles
Posted by Ed Davis, DPM on 5/09/05 at 22:14 View Thread
Patents with arthritic knees have had, for some time, the option of injections with sodium hyaluronate (Synvisc or Hyalgan) which is basically a synthetic joint fluid. For some reason, when the effect of the hydraulic pressure created by the injection wears off, the body is somehow stimulated to create nw joint fluid on its own. this has been a means of stalling or preventing knee joint replacement surgery for years.
Several years ago, a group of podiatrists including myself started injecting Hyalgan into arthritic ankles as an off label treatment. The dilemna was that since the Hyalgan was 'off label' no insurance company would pay for it. Patients had to pay out of pocket for the injection. It involved a series of 3 injections of 20 mg. of Hyalgan, one per week for 3 weeks per ankle. The results have been excellent. John Marty, DPM of Pittsburgh, PA is in the process of writing up a research project for this in order to try to get FDA approval.
The good news is that a third player has just entered the market, Supartz brand sodium hyaluronate, manufacutred by Smith and Nephew and presumably equal in chemical composition to Hyalgan. Supartz is considerably less expensive than Hyalgan which is less expensive than Synviisc.
The introduction of Supartz should make treatment of arthritic ankles more available to patients and offer good relief and as probable surgery prevention in many cases. This took a bit of investigating because Smith and Nephew cannot detail Supartz for ankles due to FDA restrictions.
Re: GOOD NEWS FOR PATIENTS WITH ARTHRITIC ANKLESDr. Zuckerman on 5/10/05 at 16:58 (174657)